Total Payments
$931,545
2024 Payments
$187,285
Companies
17
Transactions
1,513
Payment Breakdown by Category
Other$769,489 (82.6%)
Travel$106,259 (11.4%)
Food & Beverage$32,049 (3.4%)
Consulting$23,700 (2.5%)
Education$48.52 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $769,489 | 313 | 82.6% |
| Travel and Lodging | $106,259 | 620 | 11.4% |
| Food and Beverage | $32,049 | 569 | 3.4% |
| Consulting Fee | $23,700 | 8 | 2.5% |
| Education | $48.52 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $286,261 | 416 | $0 (2024) |
| ITI, Inc. | $206,539 | 306 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $206,172 | 431 | $0 (2021) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $98,753 | 138 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $53,443 | 67 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $26,273 | 34 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $22,508 | 23 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $14,407 | 31 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $8,383 | 17 | $0 (2021) |
| ABBVIE INC. | $8,000 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $187,285 | 269 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($98,753) |
| 2023 | $90,410 | 138 | ITI, Inc. ($87,512) |
| 2022 | $99,030 | 146 | ITI, Inc. ($68,919) |
| 2021 | $89,360 | 113 | ITI, Inc. ($35,679) |
| 2020 | $36,825 | 49 | Alkermes, Inc. ($16,115) |
| 2019 | $125,714 | 193 | Sunovion Pharmaceuticals Inc. ($64,784) |
| 2018 | $160,467 | 332 | Sunovion Pharmaceuticals Inc. ($81,177) |
| 2017 | $142,454 | 273 | Alkermes, Inc. ($78,013) |
All Payment Transactions
1,513 individual payment records from CMS Open Payments — Page 1 of 61
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,876.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,876.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $180.90 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $104.78 | General |
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $95.94 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $57.78 | General |
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $47.00 | General |
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $132.45 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $392.45 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,322.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $335.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $174.20 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $155.64 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $79.24 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $72.66 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $66.26 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $9.47 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/04/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $615.45 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,984.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $210.97 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $121.60 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $9.47 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,876.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/21/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/21/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $433.97 | General |
| Category: SCHIZOPHRENIA | ||||||
About Dr. Lawrence Reccoppa, MD
Dr. Lawrence Reccoppa, MD is a Psychiatry healthcare provider based in Gainesville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215095534.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lawrence Reccoppa, MD has received a total of $931,545 in payments from pharmaceutical and medical device companies, with $187,285 received in 2024. These payments were reported across 1,513 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($769,489).
Ad
Practice Information
- Specialty Psychiatry
- Location Gainesville, FL
- Active Since 12/06/2006
- Last Updated 02/11/2014
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215095534
Products in Payments
- CAPLYTA (Drug) $305,292
- LATUDA (Drug) $206,129
- Aristada 441 mg (Drug) $150,814
- ARISTADA (Drug) $107,250
- LYBALVI (Drug) $27,925
- FANAPT (Drug) $26,273
- COBENFY (Drug) $22,549
- VRAYLAR (Drug) $8,052
- QELBREE (Drug) $5,793
- INGREZZA (Drug) $378.10
- Vivitrol 380 mg (Drug) $215.32
- REXULTI (Drug) $179.40
- INVEGA SUSTENNA (Drug) $94.72
- AUSTEDO (Drug) $91.31
- Austedo XR (Drug) $64.30
- VIVITROL (Drug) $57.04
- Auvelity (Drug) $45.58
- ABILIFY MAINTENA (Drug) $41.76
- UZEDY (Drug) $21.89
- SPRAVATO (Drug) $21.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Gainesville
Shahzad Hashmi, M.d.,, M.D.,
Psychiatry — Payments: $65,221
Psychiatry $65,221
Dr. Wayne Goodman, Md, MD
Psychiatry — Payments: $25,379
Psychiatry $25,379
Dr. Jordan Brown, M.d, M.D
Psychiatry — Payments: $24,910
Psychiatry $24,910
Dr. Amparo Benitez-Broome, D.o, D.O
Psychiatry — Payments: $9,518
Psychiatry $9,518
Mrs. Lisa Wirth, Md, MD
Psychiatry — Payments: $8,749
Psychiatry $8,749
Dr. Kenneth Goolsby, M.d, M.D
Psychiatry — Payments: $7,746
Psychiatry $7,746